MIND-AMD Study: a Multidisciplinary Investigation of Neuroretinal Damage in Age-related Macular Degeneration.

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Age-Related (Dry) Macular Degeneration; Age-Related Macular Degeneration (AMD); AMD Population – Intermediate or Advanced AMD; AMD and Macular Edema; Neovascular (Wet) Age-Related Macular Degeneration Sponsors: IRCCS San Raffaele; Fondazione IRCCS...

[Trial of device that is not approved or cleared by the U.S. FDA]

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Sponsors: [Redacted] Withheld Sponsors: [Redacted] Withheld 

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Obesity; Overweight and/or Obesity; Overweight; Treatment Of Obesity Interventions: Drug: Semaglutide; Drug: Tirzepatide; Drug: Berobenatide Sponsors: Pfizer Not yet recruiting Conditions: Obesity; Overweight and/or Obesity; Overweight; Treatment Of...

NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity; Obesity Interventions: Drug: GLP-1 Receptor Agonist Therapy Sponsors: Istanbul Saglik Bilimleri University Not yet recruiting Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity;...

Predicting Early Circulatory Deterioration After Short-Acting Beta-Blocker Treatment in Intensive Care Patients

by palligoelme@gmail.com | Sep 29, 2026 | Clinical Trials

​ Conditions: Critical Illness Interventions: Drug: Esmolol; Drug: Landiolol Sponsors: Shanghai Zhongshan Hospital Completed Conditions: Critical Illness Interventions: Drug: Esmolol; Drug: Landiolol Sponsors: Shanghai Zhongshan Hospital...